AU2001234088A1 - TNF-alpha inhibitors - Google Patents

TNF-alpha inhibitors

Info

Publication number: AU2001234088A1
Authority: AU; Australia
Prior art keywords: tnf; alpha inhibitors; inhibitors; alpha
Prior art date: 2000-02-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001234088A

Other versions

AU2001234088B2 (en

Inventor

Kazuaki Ikeya

Takahito Kitayoshi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-18

Filing date

2001-02-15

Publication date

2001-11-08

2001-02-15 Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd

2001-02-15 Priority claimed from PCT/JP2001/001069 external-priority patent/WO2001060362A1/en

2001-11-08 Publication of AU2001234088A1 publication Critical patent/AU2001234088A1/en

2004-11-11 Assigned to TAKEDA PHARMACEUTICAL COMPANY LIMITED reassignment TAKEDA PHARMACEUTICAL COMPANY LIMITED Amend patent request/document other than specification (104) Assignors: TAKEDA CHEMICAL INDUSTRIES, LTD.

2005-12-01 Application granted granted Critical

2005-12-01 Publication of AU2001234088B2 publication Critical patent/AU2001234088B2/en

2021-02-15 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

239000002452 tumor necrosis factor alpha inhibitor Substances 0.000 title 1

AU2001234088A 2000-02-18 2001-02-15 Tnf-alpha inhibitors Ceased AU2001234088B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000-46828		2000-02-18
JP2000046828		2000-02-18
PCT/JP2001/001069 WO2001060362A1 (en)	2000-02-18	2001-02-15	TNF-α INHIBITORS

Publications (2)

Publication Number	Publication Date
AU2001234088A1 true AU2001234088A1 (en)	2001-11-08
AU2001234088B2 AU2001234088B2 (en)	2005-12-01

Family

ID=18569174

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU3408801A Withdrawn AU3408801A (en)	2000-02-18	2001-02-15	Tnf-alpha inhibitors
AU2001234088A Ceased AU2001234088B2 (en)	2000-02-18	2001-02-15	Tnf-alpha inhibitors

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU3408801A Withdrawn AU3408801A (en)	2000-02-18	2001-02-15	Tnf-alpha inhibitors

Country Status (10)

Country	Link
US (1)	US6833381B2 (en)
EP (1)	EP1262180A4 (en)
KR (1)	KR20030016229A (en)
CN (1)	CN1404390A (en)
AU (2)	AU3408801A (en)
CA (1)	CA2400124C (en)
HU (1)	HUP0301057A3 (en)
NO (1)	NO20023913L (en)
PL (1)	PL356422A1 (en)
WO (1)	WO2001060362A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100224601B1 (en) *	1997-05-13	1999-10-15	윤종용	The automatic feeder of complex image forming apparatus
WO2002034263A1 (en) *	2000-10-25	2002-05-02	Takeda Chemical Industries, Ltd.	Preventives/remedies for portal hypertension
CA2436361C (en) *	2001-01-29	2010-11-02	Takeda Chemical Industries, Ltd.	Angiotensin ii antagonistic compound for use as analgesic and antiinflammatory agent
US6555581B1 (en)	2001-02-15	2003-04-29	Jones Pharma, Inc.	Levothyroxine compositions and methods
MXPA03009622A (en) *	2001-04-23	2005-03-07	Amaxa Gmbh	Buffer solution for electroporation and a method comprising the use of the same.
CA2466659A1 (en) *	2001-11-13	2003-05-22	Takeda Chemical Industries, Ltd.	Anticancer agents
AU2002349673A1 (en) *	2001-12-03	2003-06-17	Takeda Chemical Industries, Ltd.	Insulin resistance improving agents
JP4484427B2 (en) *	2001-12-03	2010-06-16	武田薬品工業株式会社	Insulin resistance improving agent
US20040209803A1 (en) *	2002-12-19	2004-10-21	Alain Baron	Compositions for the treatment and prevention of nephropathy
US7790681B2 (en) *	2002-12-17	2010-09-07	Amylin Pharmaceuticals, Inc.	Treatment of cardiac arrhythmias with GLP-1 receptor ligands
EP1579872B8 (en) *	2002-12-27	2012-11-07	Takeda Pharmaceutical Company Limited	Body weight gain inhibitor
US20050201989A1 (en) *	2004-02-19	2005-09-15	St. Camillus Medical, Inc.	Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitors of tumor necrosis factor-alpha
CN101163489A (en) *	2004-04-23	2008-04-16	细胞基因公司	Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension
PL1750862T3 (en) *	2004-06-04	2011-06-30	Teva Pharma	Pharmaceutical composition containing irbesartan
US20050288272A1 (en) *	2004-06-23	2005-12-29	Solvay Pharmaceuticals Gmbh	Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
EP1784398A1 (en) *	2004-09-02	2007-05-16	Teva Pharmaceutical Industries Ltd	Purification of olmesartan medoxomil
US20070054948A1 (en) *	2004-09-02	2007-03-08	Lilach Hedvati	Purification of olmesartan medoxomil
US8506934B2 (en)	2005-04-29	2013-08-13	Robert I. Henkin	Methods for detection of biological substances
ATE526963T1 (en) *	2006-05-04	2011-10-15	Lek Pharmaceuticals	PHARMACEUTICAL COMPOSITION CONTAINING OLMESARTAN-MEDOXOMIL
WO2008095136A2 (en)	2007-01-31	2008-08-07	Henkin Robert I	Methods for detection of biological substances
BRPI0809522A2 (en) *	2007-03-28	2014-10-14	Takeda Pharmaceutical	SOLID PHARMACEUTICAL COMPOSITION, METHODS TO STABILIZE A COMPOUND, AND TO IMPROVE DISSOLUTION OF A COMPOUND, AND USE OF A PH CONTROL AGENT.
US8580801B2 (en)	2008-07-23	2013-11-12	Robert I. Henkin	Phosphodiesterase inhibitor treatment
US8236843B2 (en)	2008-09-02	2012-08-07	Elder Pharmaceuticals Ltd.	Anti inflammatory compounds
US9550737B2 (en)	2012-06-11	2017-01-24	Ucb Biopharma Sprl	TNF -α modulating benzimidazoles
GB201321733D0 (en)	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
GB201321746D0 (en)	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
EP3108245B1 (en)	2014-02-18	2020-07-22	Robert I. Henkin	Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
GB201620948D0 (en) *	2016-12-09	2017-01-25	Ucb Biopharma Sprl	Therapeutic agents
KR20190140011A (en) *	2017-04-28	2019-12-18	아사나 바이오사이언시스 엘엘씨	Formulations, methods, kits, and dosage forms for treating atopic dermatitis and improving the stability of active pharmaceutical ingredients

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5196444A (en) *	1990-04-27	1993-03-23	Takeda Chemical Industries, Ltd.	1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5605919A (en)	1993-02-26	1997-02-25	Takeda Chemical Industries, Ltd.	Treatment for viral diseases
CA2115985A1 (en)	1993-02-25	1994-08-26	Kohei Nishikawa	Vascular hypertrophy suppressor
JP3810020B2 (en)	1993-04-22	2006-08-16	武田薬品工業株式会社	Preventive or therapeutic agent for kidney disease
US5721263A (en) *	1993-06-07	1998-02-24	Takeda Chemical Industries, Ltd.	Pharmaceutical composition for angiotensin II-mediated diseases
US5824696A (en)	1993-09-01	1998-10-20	Smithkline Beecham Corporation	Medicaments
WO1995021609A1 (en)	1994-02-08	1995-08-17	Ciba-Geigy Ag	Treatment of normotensive glaucoma with angiotensin ii antagonists
SE9501881D0 (en)	1995-05-19	1995-05-19	Astra Ab	New pharmacological use of AII receptor antagonists
EP0831911B1 (en) *	1995-06-07	2002-04-17	G.D. Searle & Co.	Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
EP0835106A4 (en) *	1995-06-30	1998-09-30	Merck & Co Inc	Method of treating renal disease using an ace inhibitor and an aii antagonist
SI0914158T2 (en)	1996-04-05	2006-04-30	Takeda Chemical Industries Ltd	Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity
KR20000070046A (en) *	1997-01-10	2000-11-25	폴락 돈나 엘.	Use of angiotensin Ⅱ antagonists to treat symptomatic heart failure
AU747110B2 (en) *	1998-02-25	2002-05-09	Merck & Co., Inc.	Method for decreasing QT dispersion or inhibiting the progression of QT dispersion with an angiotensin II receptor antagonist
BR9908474A (en) *	1998-03-04	2000-12-05	Takeda Chemical Industries Ltd	Extended release preparation, process for producing an extended release preparation, and pharmaceutical composition
JP2000159671A (en)	1998-12-01	2000-06-13	Takeda Chem Ind Ltd	Arterialization inhibitor

2001
- 2001-02-15 HU HU0301057A patent/HUP0301057A3/en unknown
- 2001-02-15 EP EP01906130A patent/EP1262180A4/en not_active Withdrawn
- 2001-02-15 AU AU3408801A patent/AU3408801A/en not_active Withdrawn
- 2001-02-15 KR KR1020027010709A patent/KR20030016229A/en not_active Application Discontinuation
- 2001-02-15 CA CA2400124A patent/CA2400124C/en not_active Expired - Fee Related
- 2001-02-15 PL PL01356422A patent/PL356422A1/en not_active Application Discontinuation
- 2001-02-15 AU AU2001234088A patent/AU2001234088B2/en not_active Ceased
- 2001-02-15 CN CN01805019A patent/CN1404390A/en active Pending
- 2001-02-15 US US10/203,805 patent/US6833381B2/en not_active Expired - Fee Related
- 2001-02-15 WO PCT/JP2001/001069 patent/WO2001060362A1/en active IP Right Grant
2002
- 2002-08-16 NO NO20023913A patent/NO20023913L/en not_active Application Discontinuation

Publication	Publication Date	Title
AU2001234088A1 (en)	2001-11-08	TNF-alpha inhibitors
AU2001258771A1 (en)	2001-11-26	-secretase inhibitors
AU3408801A (en)	2001-08-27	Tnf-alpha inhibitors
AU2002219555A1 (en)	2003-01-23	VLA-4 Inhibitors
AU2001260674A1 (en)	2002-02-28	TNF-alpha production inhibitors
AU2001244399A1 (en)	2001-10-23	Gamma-secretase inhibitors
AU2001237041A1 (en)	2001-11-08	Kinase inhibitors
AU2001296961A1 (en)	2002-04-08	17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU4882101A (en)	2001-11-12	Mmp-12 inhibitors
AU2002211663A1 (en)	2002-04-22	Nf-$g(k)b inhibitors
AU2001285750A1 (en)	2002-03-14	Urokinase inhibitors
AU5248800A (en)	2001-09-24	Fading inhibitors
AU2001247589A1 (en)	2001-10-03	Non-amidine containing protease inhibitors
AU2001294557A1 (en)	2002-03-26	Thrombin inhibitors
AU2001236052A1 (en)	2001-11-29	Urease inhibitors
AU2002211662A1 (en)	2002-04-22	Nf-kappab inhibitors
AU2002222627A1 (en)	2002-06-24	Tak1 inhibitors
AU2001255090A1 (en)	2001-11-12	Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2001244562A1 (en)	2001-10-08	Neovascularization inhibitors
AU2001232245A1 (en)	2001-08-20	Tnf- alpha inhibitors
AU3235100A (en)	2000-09-04	Prothease inhibitors
AU2002224550A1 (en)	2002-02-05	Corrosion inhibitors
AU1588901A (en)	2001-06-06	Protease inhibitors
AU2001220281A1 (en)	2002-05-27	Rollerboard for road-skiing
AU1474801A (en)	2001-06-06	Protease inhibitors